Welcome to our dedicated page for Callan JMB news (Ticker: CJMB), a resource for investors and traders seeking the latest updates and insights on Callan JMB stock.
Callan JMB Inc. provides integrative logistics services for healthcare organizations and emergency management agencies, including fulfillment, storage, monitoring, cold-chain logistics and specialized distribution. Company updates commonly address emergency preparedness contracts, reverse distribution of vaccines and pharmaceuticals, regulated product handling, government relationships and business updates tied to healthcare supply-chain resilience.
Recurring developments also include the Atlas Complex in Marion, Alabama, a medical, pharmaceutical and logistics campus supporting QA/QC, cold-chain logistics, warehousing and domestic distribution. Other updates cover pharmaceutical onshoring initiatives, independent manufacturing oversight, quality-control governance, collaboration activity with life-sciences partners, financial results, investor communications and legal or listing-related corporate matters.
Callan JMB (Nasdaq: CJMB) announced that its subsidiary Callan Power will designate Andy Weigman as Senior Vice President of Land and Acquisitions upon closing the previously announced asset acquisition from Reger Oil. Weigman will oversee Callan Power’s oil and gas land, operations, and acquisition functions.
Weigman brings 14 years of Williston Basin experience, including nine years at Northern Oil and Gas, where he worked with Callan Power President Mike Reger and helped build NOG into a large publicly traded non-operated E&P company. According to Callan JMB, he has sourced more than $1 billion in potential acquisition opportunities across over 900 wells.
The company reiterated its plan to build a disciplined, scalable non-operated working interest platform in the Williston Basin of North Dakota and Montana, participating in wells operated by others in exchange for a proportionate share of capital, production, and cash flow while avoiding field operations.
Callan JMB (NASDAQ:CJMB) will appoint Northern Oil and Gas founder Michael Reger as President of its new wholly owned subsidiary, Callan Power, effective upon closing of Callan JMB’s previously announced acquisition of assets from Reger Oil. Callan Power will focus on oil and gas development, energy resilience, grid reliability, and domestic manufacturing of transformers and other critical electrical equipment.
Reger, who helped lead Northern Oil and Gas through a $650 million recapitalization and about $850 million in acquisitions while growing production above 40,000 BOE/d, will receive no cash salary and be compensated in equity. Callan Power plans headquarters at the Atlas Complex in Marion, Alabama, with additional manufacturing in Brewton, and aims to support U.S. electrical-infrastructure needs across utilities, data centers, AI, and other energy-intensive sectors.
Callan JMB (NASDAQ: CJMB) announced that subsidiary Callan Power has signed a definitive deal to acquire certain Williston Basin oil and gas assets from Reger Oil, anchored by a 23-well Red River drilling program.
The wells are scheduled at roughly one per month from May 2027 through March 2029. Callan Power will hold a 75% working interest and about 83% net revenue interest, with Chandler Energy holding the remaining 25% working interest and serving as operator. Based on internal assumptions, the program is projected to generate approximately $252 million in cumulative net operating cash flow to Callan Power over the wells’ lives, with positive cash flow in the first drilling year, about $25 million in 2028 and $42 million in 2029. These estimates assume flat $75/bbl oil and 7.3 million gross barrels of ultimate recovery and have not been independently audited. Upon closing, Michael Reger will become President of Callan Power and join the Callan JMB board, supporting the company’s expansion of its critical-infrastructure strategy into domestic energy development.
Callan JMB (Nasdaq: CJMB) announced that on August 14, 2026, Nasdaq’s Listing Qualifications Department notified the company it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. The compliance matter is now closed. Callan JMB had previously received notice on June 29, 2026 that its common stock was not in compliance after trading below $1.00 for 30 consecutive business days. According to the company, compliance was restored because its closing bid price was at least $1.00 per share for more than 10 consecutive business days, thereby satisfying Nasdaq’s Minimum Bid Price Requirement.
Callan JMB (NASDAQ: CJMB), Bia Power Systems and Alabama State University announced a strategic joint venture to establish an advanced transformer and electrical‑equipment manufacturing and assembly facility in Brewton, Alabama, with an anticipated investment of approximately $60 million.
The ASU-owned site is expected to serve utilities, data centers, industrial operators and renewable‑energy developers across North America. At full planned scale, the venture is projected to support more than $150 million in annual manufacturing revenue, generate $25–$40 million in first‑year revenue and $100–$150 million by year three, and target gross margins of 25–35%. Management projects 150–250 direct jobs in Alabama and more than $200 million in regional economic impact over five years. According to Callan JMB, the project advances its Callan Power strategy in domestic transformer manufacturing, grid reliability and energy resilience while reshoring production currently performed in China.
Callan JMB (NASDAQ: CJMB) reported successful completion of its emergency preparedness support for the City of Chicago during the 2026 Lollapalooza weekend. The integrative logistics company backed city operations as approximately 460,000 attendees visited Grant Park for 172 musical acts over four days.
According to Callan JMB, this engagement extends a partnership with Chicago that began in 2009 during the H1N1 response and has continued through major events requiring heightened preparedness. The company’s services in Chicago include medical supply management, compliant storage, inventory oversight, logistical coordination and support for deploying critical resources.
Callan JMB (NASDAQ: CJMB) has formed Callan Power LLC, a wholly owned subsidiary focused on strengthening U.S. electrical infrastructure through planned domestic manufacturing of transformers and other critical power-system equipment. The business will be based at the Atlas Complex in Alabama, with future operations planned at an Alabama State University-owned facility in Brewton.
Callan Power intends to offer power and distribution transformers, specialized units for renewable energy, mobile substations, battery energy‑storage systems, advanced power cables, and power‑system engineering, testing and simulation. According to Callan JMB, the subsidiary builds on more than 15 years of emergency power-management experience from its Coldchain Technology Services unit and is expected to support grid-resilience, emergency‑power preparedness, and workforce development in Alabama.
Callan JMB (NASDAQ: CJMB) entered a long-term strategic support services agreement with Cavalry 1838 Equine Biosciences, tied to the Atlas Complex healthcare and life sciences campus strategy. Under the agreement, Callan JMB will provide infrastructure and operational services for Cavalry 1838’s commercialization activities.
According to Callan JMB, the company is entitled to 60% of revenue generated by the Cavalry 1838 enterprise, expanding its recurring infrastructure services business. The enterprise’s base-case business plan contemplates $12–$25 million in annual revenue within seven years. Cavalry 1838 will operate from the Atlas Complex in Alabama, with Kansas as the primary serum collection and production facility, focusing on equine-derived biologics such as pharmaceutical-grade serum, plasma and specialty biologic products. Callan JMB’s Atlas Complex will supply regulatory, quality, logistics, warehousing, distribution, administrative, scientific and commercialization support through its Equine Center.
Callan JMB (NASDAQ: CJMB) announced ground-breaking at the Atlas Complex in Marion, Alabama, marking completion of a strategic partnership with Alabama State University to develop an integrated pharmaceutical manufacturing ecosystem aimed at strengthening U.S. domestic production, supply chain resilience, and national medical preparedness.
The partnership includes the launch of the Marion 9 Biomanufacturing Center, where Callan JMB will provide logistics, compliance, warehousing, facility leasing, and supply chain management infrastructure. According to Callan JMB, the project is forecast to generate an estimated $500 million in annual gross revenues, with the company entitled to a 21% participation, implying approximately $105 million in first-year revenue and over $400 million over a five-year agreement.
The Atlas Complex is intended as a shared healthcare and life sciences campus supporting academic, industry, healthcare, and government collaborators, with forecasts of more than 150 direct high-skilled jobs and about 300 indirect jobs across Alabama.
Callan JMB (NASDAQ: CJMB) announced a strategic partnership with Alabama State University to develop an integrated U.S. pharmaceutical manufacturing ecosystem aimed at enhancing domestic production, supply chain resilience, workforce development, and national medical preparedness.
Under the agreement, Callan JMB would provide operational infrastructure, including logistics, regulatory compliance, warehousing, facility leasing, supply chain management, housing support, and related services. Callan JMB would receive 21% of gross revenue from qualifying pharmaceutical manufacturing operations. Management believes the initiative could represent a potential $414 million five-year revenue opportunity and, under current assumptions, could ultimately support annual gross revenues approaching $500 million, implying about $105 million in annual revenue to Callan JMB, subject to successful execution. An official partnership announcement is scheduled for July 16, 2026, with university, industry, government, and community leaders.